BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/11/2023 11:04:23 AM | Browse: 97 | Download: 216
 |
Received |
|
2023-04-27 17:58 |
|
Peer-Review Started |
|
2023-04-27 18:01 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-05-19 07:21 |
|
Revised |
|
2023-05-20 03:44 |
|
Second Decision |
|
2023-06-08 03:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-06-19 17:59 |
|
Articles in Press |
|
2023-06-19 17:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-06-21 09:46 |
|
Typeset the Manuscript |
|
2023-08-04 10:35 |
|
Publish the Manuscript Online |
|
2023-08-11 11:04 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Deven Juneja, Prashant Nasa, Ravi Jain and Omender Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Deven Juneja, FCCP, MD, Director, Department of Institute of Critical Care Medicine, Max Super Speciality Hospital, Saket, 1, Press Enclave Road, New Delhi 110017, India. devenjuneja@gmail.com |
| Key Words |
Canagliflozin; Empagliflozin; Euglycemia; Diabetes mellitus; Diabetic ketoacidosis; Sodium-glucose cotransporter-2 inhibitors; Sodium-glucose cotransporter-2 |
| Core Tip |
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a newer class of oral hypoglycemic drugs commonly prescribed for managing patients with diabetes mellitus. Even though these drugs are effective in controlling blood glucose and have favourable cardiac effects, they may rarely lead to the development of euglycemic diabetic ketoacidosis (EDKA), which may complicate the disease course of these patients. Certain risk factors, like severe acute illness and major surgery, may predispose these patients to develop EDKA. The signs and symptoms of EDKA are similar to classic symptoms of diabetic ketoacidosis, but these patients have normal blood glucose levels, making the diagnosis difficult. Hence, a higher index of suspicion is warranted in such patients, as delay in diagnosis may lead to higher morbidity and mortality. |
| Publish Date |
2023-08-11 11:04 |
| Citation |
Juneja D, Nasa P, Jain R, Singh O. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports. World J Diabetes 2023; 14(8): 1314-1322 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i8/1314.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i8.1314 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
